ELCELYX THERAPEUTICS
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic... market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
ELCELYX THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2010-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.elcelyx.com
Total Employee:
11+
Status:
Active
Contact:
(858) 876-1814
Email Addresses:
[email protected]
Total Funding:
96.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Pound Sterling OpenResty
Current Advisors List
Founder
Investors List
Clough Capital Partners
Clough Capital Partners investment in Series E - Elcelyx Therapeutics
Morgenthaler Ventures
Morgenthaler Ventures investment in Series E - Elcelyx Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series E - Elcelyx Therapeutics
Technology Partners
Technology Partners investment in Series E - Elcelyx Therapeutics
Sailing Capital
Sailing Capital investment in Series E - Elcelyx Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series E - Elcelyx Therapeutics
GSM Fund
GSM Fund investment in Series E - Elcelyx Therapeutics
Kleiner Perkins
Kleiner Perkins investment in Series C - Elcelyx Therapeutics
Technology Partners
Technology Partners investment in Series C - Elcelyx Therapeutics
Morgenthaler Ventures
Morgenthaler Ventures investment in Series C - Elcelyx Therapeutics
Official Site Inspections
http://www.elcelyx.com
- Host name: 104.21.81.175
- IP address: 104.21.81.175
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
